What are the main factors affecting the outcome of tocilizumab therapy in COVID-19-induced cytokine release syndrome?
{{output}}
Objective: Recommendations for the treatment of cytokine release syndrome/macrophage activation syndrome (MAS) associated with coronavirus disease-2019 (COVID-19) are still of poor quality. IL-6 is an important therapeutic target... ...
